In this important session, I delved into a topic that many may find controversial but is grounded in scientific fact. I’ve spent years researching this, and the paper I’m discussing today, published on September 27, 2024, in Nature Medicine, provides insights that challenge the current pandemic narrative. The implications of this research are significant, particularly in understanding the waning immunity from mRNA COVID vaccines.
This isn't about being anti-vax; it's about asking the right questions. Over the course of the pandemic, it’s become evident that after each booster shot, antibody levels drop quickly—sometimes within weeks—and by six months, a new booster is needed. This paper, examining long-term immunity, helps explain why: the mRNA vaccine does not lead to the establishment of long-lived plasma cells in the bone marrow, as other vaccines like those for tetanus and flu do. The immune system isn't keeping a memory of the spike protein.
To make sense of this, I compared this phenomenon to how the body reacts to gram-negative bacteria and their endotoxins. The immune system faces the infection but doesn’t retain a memory of it because remembering these toxins could lead to chronic diseases, inflammation, and even autoimmunity. Similarly, the immune system appears to be treating the spike protein from the mRNA vaccine as a toxin, refusing to retain it in long-term memory due to the potential for harmful autoimmune responses.
The paper's findings suggest that no matter how many doses of the vaccine are administered, long-lived immunity is unlikely to occur. This raises a critical question: why are we continuing to push boosters if the immune system is actively avoiding the spike protein? Public health strategies need to revisit the basics and reconsider their approach, especially since there is no long-term immunity being developed.
This revelation leaves us in a precarious situation where the current strategy is failing. With no long-term immunity and no alternatives, it’s time for the scientific community to ask some tough questions. What do we do next?
I’ll continue to ask these challenging questions and keep you updated as we navigate these complex times. Thank you for joining me, and I hope this session encourages deep reflection on the current trajectory of public health policy.
Share this post